Using the ELDA (Extreme Limiting Dilution Analysis) software we estimated that the cancer cell-initiating frequency of double-positive (1/1756) was eight times higher in comparison to the one of L1CAM+/CD133− (1/14749) and eight times higher than SKOV3ip wild-type cells (1/13963). The gene discussed is L1CAM; the disease is cancer.